Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.


Business Focus: Pharmaceuticals

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEC Form 4 filings for SHMN*US within the last 6 months
See all filings within the past 6 months

Company News

Mar 20, 2023 09:30 ET
SOHM, Inc. Introduces and Received Topical Skincare Line of Products Orders in Its Label
CHINO HILLS, CA / ACCESSWIRE / March 20, 2023 / SOHM, Inc. (OTC PINK:SHMN) (the "Company"), a generic pharmaceutical, nutraceutical, and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today introductions of its Topical Skincare line of products.
Read full article
Oct 18, 2022 09:30 ET
SOHM, Inc. Signs MOU with London/Asia-Based Fund to Infuse Funds for Various Projects
CHINO HILLS, CA / ACCESSWIRE / October 18, 2022 / SOHM, Inc. (OTC PINK:SHMN) (the "Company"), a generic pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today that it has signed a memorandum of understanding with SRAM & MRAM Group for injections of required funds for the Company's various new pipeline projects.
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

SOHM, Inc. is a pharmaceutical manufacturer that produces and markets generic drugs for various treatment categories. The Company is focused on developing, manufacturing and distributing generic, branded generic, private label pharmaceuticals, cosmeceuticals and nutraceutical products. The Company has expertise in various drug delivery technologies, including solid dosage from, oral-controlled and sustained releases semi-solid, liquid, oral trans mucosal, transdermal, gel, injectable, and other drug delivery technologies, and the application of these technologies to drug forms. Its product list includes analgesics, antibiotics, anti-cold, anti-flammatory, beta-lactum antibodies, capsules, drops, injections, suspension, syrup, tablets, vitamins and tonics. The Company markets and sells its generic drugs globally and focuses primarily on markets in Africa, Latin America, Southeast Asia and the European Union.

See business summary



Search (past week) for $SHMN